|
1
|
Guariguata L, Whiting DR, Hambleton I,
Beagley J, Linnenkamp U and Shaw JE: Global estimates of diabetes
prevalence for 2013 and projections for 2035. Diabetes Res Clin
Pract. 103:137–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Samuel VT, Petersen KF and Shulman GI:
Lipid-induced insulin resistance: Unravelling the mechanism.
Lancet. 375:2267–2277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fabbrini E and Magkos F: Hepatic steatosis
as a marker of metabolic dysfunction. Nutrients. 7:4995–5019. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Monsénégo J, Mansouri A, Akkaoui M, Lenoir
V, Esnous C, Fauveau V, Tavernier V, Girard J and Prip-Buus C:
Enhancing liver mitochondrial fatty acid oxidation capacity in
obese mice improves insulin sensitivity independently of hepatic
steatosis. J Hepatol. 56:632–639. 2012. View Article : Google Scholar
|
|
5
|
Forman BM, Goode E, Chen J, Oro AE,
Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW,
et al: Identification of a nuclear receptor that is activated by
farnesol metabolites. Cell. 81:687–693. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ryan KK, Tremaroli V, Clemmensen C,
Kovatcheva-Datchary P, Myronovych A, Karns R, Wilson-Pérez HE,
Sandoval DA, Kohli R, Bäckhed F and Seeley RJ: FXR is a molecular
target for the effects of vertical sleeve gastrectomy. Nature.
509:183–188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duran-Sandoval D, Cariou B, Percevault F,
Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC,
Kuipers F and Staels B: The farnesoid X receptor modulates hepatic
carbohydrate metabolism during the fasting-refeeding transition. J
Biol Chem. 280:29971–29979. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Lee FY, Barrera G, Lee H, Vales
C, Gonzalez FJ, Willson TM and Edwards PA: Activation of the
nuclear receptor FXR improves hyperglycemia and hyperlipidemia in
diabetic mice. Proc Natl Acad Sci USA. 103:1006–1011. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cariou B, van Harmelen K, Duran-Sandoval
D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G,
Fruchart JC, Gonzalez FJ, et al: The farnesoid X receptor modulates
adiposity and peripheral insulin sensitivity in mice. J Biol Chem.
281:11039–11049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Downes M, Verdecia MA, Roecker AJ, Hughes
R, Hogenesch JB, Kast-Woelbern HR, Bowman ME, Ferrer JL, Anisfeld
AM, Edwards PA, et al: A chemical, genetic, and structural analysis
of the nuclear bile acid receptor FXR. Mol Cell. 11:1079–1092.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang S, Suh JM, Reilly SM, Yu E, Osborn O,
Lackey D, Yoshihara E, Perino A, Jacinto S, Lukasheva Y, et al:
Intestinal FXR agonism promotes adipose tissue browning and reduces
obesity and insulin resistance. Nat Med. 21:159–165. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong B, Luyendyk JP, Tawfik O and Guo GL:
Farnesoid X receptor deficiency induces nonalcoholic
steatohepatitis in low-density lipoprotein receptor-knockout mice
fed a high-fat diet. J Pharmacol Exp Ther. 328:116–122. 2009.
View Article : Google Scholar :
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Das M, Das S, Lekli I and Das DK: Caveolin
induces cardio-protection through epigenetic regulation. J Cell Mol
Med. 16:888–895. 2012. View Article : Google Scholar
|
|
15
|
Kong Q, Zhang H, Zhao T, Zhang W, Yan M,
Dong X and Li P: Tangshen formula attenuates hepatic steatosis by
inhibiting hepatic lipogenesis and augmenting fatty acid oxidation
in db/db mice. Int J Mol Med. 38:1715–1726. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Oliveira PR, da Costa CA, de Bem GF, de
Cavalho LC, de Souza MA, de Lemos Neto M, da Cunha Sousa PJ, de
Moura RS and Resende AC: Effects of an extract obtained from fruits
of Euterpe oleracea Mart. in the components of metabolic syndrome
induced in C57BL/6J mice fed a high-fat diet. J Cardiovasc
Pharmacol. 56:619–626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bogdanov P, Corraliza L, Villena JA,
Carvalho AR, Garcia-Arumí J, Ramos D, Ruberte J, Simó R and
Hernández C: The db/db mouse: A useful model for the study of
diabetic retinal neurodegeneration. PLoS One. 9:e973022014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duran-Sandoval D, Mautino G, Martin G,
Percevault F, Barbier O, Fruchart JC, Kuipers F and Staels B:
Glucose regulates the expression of the farnesoid X receptor in
liver. Diabetes. 53:890–898. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han CY, Kim TH, Koo JH and Kim SG:
Farnesoid X receptor as a regulator of fuel consumption and
mitochondrial function. Arch Pharm Res. 39:1062–1074. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lambert G, Amar MJ, Guo G, Brewer HB Jr,
Gonzalez FJ and Sinal CJ: The farnesoid X-receptor is an essential
regulator of cholesterol homeostasis. J Biol Chem. 278:2563–2570.
2003. View Article : Google Scholar
|
|
21
|
Schonewille M, de Boer JF and Groen AK:
Bile salts in control of lipid metabolism. Curr Opin Lipidol.
27:295–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ronnett GV, Kleman AM, Kim EK, Landree LE
and Tu Y: Fatty acid metabolism, the central nervous system, and
feeding. Obesity (Silver Spring). 14(Suppl 5): S201–S207. 2006.
View Article : Google Scholar
|
|
23
|
Hardie DG and Pan DA: Regulation of fatty
acid synthesis and oxidation by the AMP-activated protein kinase.
Biochem Soc Trans. 30:1064–1070. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carling D, Zammit VA and Hardie DG: A
common bicyclic protein kinase cascade inactivates the regulatory
enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett.
223:217–222. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ruderman NB, Saha AK and Kraegen EW:
Minireview: Malonyl CoA, AMP-activated protein kinase, and
adiposity. Endocrinology. 144:5166–5171. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sierra AY, Gratacós E, Carrasco P, Clotet
J, Ureña J, Serra D, Asins G, Hegardt FG and Casals N: CPT1c is
localized in endoplasmic reticulum of neurons and has carnitine
palmitoyl-transferase activity. J Biol Chem. 283:6878–6885. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Noh K, Kim YM, Kim YW and Kim SG:
Farnesoid X receptor activation by chenodeoxycholic acid induces
detoxifying enzymes through AMP-activated protein kinase and
extracellular signal-regulated kinase 1/2-mediated phosphorylation
of CCAAT/enhancer binding protein β. Drug Metab Dispos.
39:1451–1459. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hawley SA, Davison M, Woods A, Davies SP,
Beri RK, Carling D and Hardie DG: Characterization of the
AMP-activated protein kinase kinase from rat liver and
identification of threonine 172 as the major site at which it
phosphorylates AMP-activated protein kinase. J Biol Chem.
271:27879–27887. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gardès C, Chaput E, Staempfli A, Blum D,
Richter H and Benson GM: Differential regulation of bile acid and
cholesterol metabolism by the farnesoid X receptor in Ldlr −/− mice
versus hamsters. J Lipid Res. 54:1283–1299. 2013. View Article : Google Scholar
|
|
30
|
Holloszy JO: Regulation by exercise of
skeletal muscle content of mitochondria and GLUT4. J Physiol
Pharmacol. 59(Suppl 7): S5–S18. 2008.
|
|
31
|
Aharoni-Simon M, Hann-Obercyger M, Pen S,
Madar Z and Tirosh O: Fatty liver is associated with impaired
activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial
biogenesis in mice. Lab Invest. 91:1018–1028. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Morris EM, Meers GM, Booth FW, Fritsche
KL, Hardin CD, Thyfault JP and Ibdah JA: PGC-1α overexpression
results in increased hepatic fatty acid oxidation with reduced
triacylglycerol accumulation and secretion. Am J Physiol
Gastrointest Liver Physiol. 303:G979–G992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Watanabe M, Houten SM, Wang L, Moschetta
A, Mangelsdorf DJ, Heyman RA, Moore DD and Auwerx J: Bile acids
lower triglyceride levels via a pathway involving FXR, SHP, and
SREBP-1c. J Clin Invest. 113:1408–1418. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Castellani LW, Sinal CJ, Gonzalez
FJ and Edwards PA: Peroxisome proliferator-activated receptor-gamma
coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism
by activation of the nuclear receptor FXR. Genes Dev. 18:157–169.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matsukuma KE, Bennett MK, Huang J, Wang L,
Gil G and Osborne TF: Coordinated control of bile acids and
lipogenesis through FXR-dependent regulation of fatty acid
synthase. J Lipid Res. 47:2754–2761. 2006. View Article : Google Scholar : PubMed/NCBI
|
